BE735439A - - Google Patents

Info

Publication number
BE735439A
BE735439A BE735439DA BE735439A BE 735439 A BE735439 A BE 735439A BE 735439D A BE735439D A BE 735439DA BE 735439 A BE735439 A BE 735439A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE735439A publication Critical patent/BE735439A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
    • G02B27/02—Viewing or reading apparatus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE735439D 1968-07-01 1969-06-30 BE735439A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74180768A 1968-07-01 1968-07-01
US78725468A 1968-12-26 1968-12-26
US81943569A 1969-04-25 1969-04-25

Publications (1)

Publication Number Publication Date
BE735439A true BE735439A (enExample) 1969-12-30

Family

ID=27419280

Family Applications (1)

Application Number Title Priority Date Filing Date
BE735439D BE735439A (enExample) 1968-07-01 1969-06-30

Country Status (7)

Country Link
BE (1) BE735439A (enExample)
CH (1) CH515911A (enExample)
DE (1) DE1932396A1 (enExample)
ES (6) ES368949A1 (enExample)
FR (1) FR2012062A1 (enExample)
GB (1) GB1256593A (enExample)
NL (1) NL6909864A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759671A (fr) * 1969-12-01 1971-06-01 Sandoz Sa Derives de la quinazolinone, leur preparation et medicaments contenant ces derives
DK129348B (da) * 1970-07-13 1974-09-30 Sumitomo Chemical Co Analogifremgangsmåde til fremstilling af 1-substituerede 3,4-dihydro-2(1H)-quinazolinonderivater.
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
WO1993004047A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
CA2124306C (en) * 1993-05-26 2004-04-06 Masami Muraoka Quinazolinone derivatives
WO2015120059A1 (en) * 2014-02-04 2015-08-13 Yates Charles Ryan Inhibitors of paxillin function and related compositions and methods

Also Published As

Publication number Publication date
ES368949A1 (es) 1971-07-16
NL6909864A (enExample) 1970-01-05
ES388760A1 (es) 1974-03-01
CH515911A (de) 1971-11-30
DE1932396A1 (de) 1970-01-08
ES388762A1 (es) 1974-03-01
FR2012062A1 (enExample) 1970-03-13
GB1256593A (enExample) 1971-12-08
ES388761A1 (es) 1974-03-01
ES388758A1 (es) 1974-03-01
ES388759A1 (es) 1974-03-01

Similar Documents

Publication Publication Date Title
AU1946070A (enExample)
AU5506869A (enExample)
AU2374870A (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
FR2027023B1 (enExample)
AU6171569A (enExample)
AU429879B2 (enExample)
AU2581067A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AR203075Q (enExample)
AU3224368A (enExample)
AU4744468A (enExample)
AU2580267A (enExample)
BE728157A (enExample)
BE642636A (enExample)
BE581157A (enExample)
BE728095A (enExample)
BE709095A (enExample)
BE726538A (enExample)
BE727610A (enExample)
BE727168A (enExample)
BE722486A (enExample)
AU4464266A (enExample)